B Cells Promote T Cell Immunosenescence and Mammalian Aging Parameters
Saad Khan,Mainak Chakraborty,Fei Wu,Nan Chen,Tao Wang,Yi Tao Chan,Azin Sayad,Juan Diego Sánchez Vásquez,Max Kotlyar,Khiem Nguyen,Yingxiang Huang,Faisal J Alibhai,Minna Woo,Ren-Ke Li,Mansoor Husain,Igor Jurisica,Adam J Gehring,Pamela S Ohashi,David Furman,Sue Tsai,Shawn Winer,Daniel A Winer
DOI: https://doi.org/10.1101/2023.09.12.556363
2023-09-14
bioRxiv
Abstract:A dysregulated adaptive immune system is a key feature of aging, and is associated with age-related chronic diseases and mortality. Most notably, aging is linked to a loss in the diversity of the T cell repertoire and expansion of activated inflammatory age-related T cell subsets, though the main drivers of these processes are largely unknown. Here, we find that T cell aging is directly influenced by B cells. Using multiple models of B cell manipulation and single-cell omics, we find B cells to be a major cell type that is largely responsible for the age-related reduction of naive T cells, their associated differentiation towards pathogenic immunosenescent T cell subsets, and for the clonal restriction of their T cell receptor (TCR). Accordingly, we find that these pathogenic shifts can be therapeutically targeted via CD20 monoclonal antibody treatment. Mechanistically, we uncover a new role for insulin receptor signaling in influencing age-related B cell pathogenicity that in turn induces T cell dysfunction and a decline in healthspan parameters. These results establish B cells as a pivotal force contributing to age-associated adaptive immune dysfunction and healthspan outcomes, and suggest new modalities to manage aging and related multi-morbidity.